We are investigating a new drug, ELVN-001, for patients with chronic myeloid leukemia. The goal is to see if it is safe and effective in treating this type of cancer.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Myeloid Leukemia (CML) is a type of cancer that starts in the blood-forming cells of the bone marrow and leads to the overproduction of myeloid cells, causing symptoms like fatigue, weight loss, and an enlarged spleen.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
